Pavel-Dinu Laboratory
Leading Research for Gene and Cell Therapies for Patients with Inborn Errors of Immunity
Environment
Our center is at the forefront of medicine, designed with outstanding research infrastructure to support cutting-edge research and technologies to help us discover, develop, and advance safe, curative, one-time therapies for patients with rare and common immune diseases. Basic and translational researchers work with clinicians in a highly collaborative environment to combine our expertise, ideas, and efforts to solve challenging biological and medical problems with broad implications in human health.
Our collaborations extend across our centers and the University of Washington, national and international institutes, and universities to bring together the best minds and science.
OUR COLLABORATORS
Dr. Luigi D. Notarangelo, MD
Chief, Laboratory of Clinical Immunology and Microbiology | NIH/NIAID
Dr. David J. Rawlings, MD, PhD
Professor of Pediatrics and Director | University of Washington School of Medicine and SCRI
Dr. Matthew Porteus, MD, PhD
Professor of Pediatrics and Director| Stanford University School of Medicine and CDCM
Dr. Eric Allenspach, MD, PhD
Associate Professor | University of Washington School of Medicine and SCRI
Dr. Adrian Piliponsky, PhD
Professor of Pediatrics | University of Washington School of Medicine and SCRI
Dr. Pejman Mohammadi, PhD
Associate Professor | University of Washington School of Medicine and SCRI
Dr. Sebastien Viel, PharmD, PhD
Professor of Immunology | Hospices Civils de Lyon
Dr. Bruce E. Torbett, PhD, MSPH
Professor of Pediatrics and co-Director | University of Washington School of Medicine and SCRI
Copyright 2024 © Mara Pavel-Dinu